NASDAQ:YMTX Yumanity Therapeutics - YMTX Insider Trading & Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Yumanity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $3.18 +0.01 (+0.32%) (As of 03/22/2023 12:00 AM ET) Add Compare Share Share Today's Range$3.18▼$3.5050-Day Range$3.17▼$8.3352-Week Range$0.95▼$13.23Volume16,291 shsAverage Volume473,083 shsMarket Capitalization$34.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Yumanity Therapeutics (NASDAQ:YMTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.45%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$69,745.94 YMTX Insider Buying and Selling by Quarter Get YMTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Yumanity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Yumanity Therapeutics Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails12/2/2022Michael D WyzgaInsiderSell3,116$1.69$5,266.0413,997 12/2/2022Richard PetersCEOSell10,890$1.69$18,404.1090,028 7/5/2022Richard PetersCEOSell4,584$1.85$8,480.40100,918 6/3/2022Devin Whittemore SmithSVPSell2,923$1.19$3,478.3717,077 6/3/2022Marie EpsteinInsiderSell1,806$1.19$2,149.1410,859 6/3/2022Richard PetersCEOSell10,206$1.19$12,145.14105,502 3/28/2022Richard PetersCEOSell10,715$1.85$19,822.75 (Data available from 1/1/2013 forward) YMTX Insider Trading Activity - Frequently Asked Questions Who is on Yumanity Therapeutics's Insider Roster? The list of insiders at Yumanity Therapeutics includes Devin Whittemore Smith, Marie Epstein, Michael D Wyzga, Paulash Mohsen, and Richard Peters. Learn more on insiders at YMTX. What percentage of Yumanity Therapeutics stock is owned by insiders? 12.45% of Yumanity Therapeutics stock is owned by insiders. Learn more on YMTX's insider holdings. Which Yumanity Therapeutics insiders have been selling company stock? The following insiders have sold YMTX shares in the last 24 months: Devin Whittemore Smith ($3,478.37), Marie Epstein ($2,149.14), Michael D Wyzga ($5,266.04), Paulash Mohsen ($3,583.14), and Richard Peters ($58,852.39). How much insider selling is happening at Yumanity Therapeutics? Insiders have sold a total of 46,198 Yumanity Therapeutics shares in the last 24 months for a total of $73,329.08 sold. This page (NASDAQ:YMTX) was last updated on 3/23/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.